SCHEMBL24181925

SCHEMBL24181925

CCC(C)C1(C)CCB(C#N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24181681 0.79 — —
SCHEMBL27522020 0.78 — —
SCHEMBL24181714 0.73 — —
SCHEMBL10082259 0.69 — —
SCHEMBL27513169 0.68 SHBG (0.33) —
SCHEMBL20008099 0.67 — —
SCHEMBL20007956 0.66 ALDH1A1 (0.33) —
SCHEMBL22758460 0.65 — —
SCHEMBL10862517 0.65 — —
SCHEMBL10862505 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3936502-A1 PYRAZINE DERIVATIVE AND APPLICATION THEREOF IN INHIBITING SHP2 Suzhou Genhouse Pharmaceutical Co., Ltd. (CN) 2022-01-12 — — EP disclosed
Send feedback